x Cell Therapy and Regenerative Med. Group, Dept. of Med., Univ. of A Coruña, A Coruña, Spain Purpose: Hydrogen sulfide, H2S, has been recently recognized as an important signaling molecule. Once exclusively thought of as a toxic gas, it is now being considered as the third gas transmitter together with NO and CO. H2S has been found to be implicated in many inflammatory pathologies and there are studies that suggest that it can act as an anti-inflammatory and anti-oxidant agent. In the present study, we analyzed the influence of two H2S donors (NaHS and GYY4137) on several aspects that characterize the inflammatory process in osteoarthritis (OA). Specifically we looked at: 1) Nitric oxide (NO) production and inducible NO synthase (iNOS) levels; 2) Production of reactive oxygen species (ROS) and antioxidant enzyme superoxide dismutase 2 (SOD2); 3) The production of prostaglandin E-2 (PGE-2); and 4) Levels of matrix metalloproteinase 3 (MMP3). Methods: Primary human chondrocytes were isolated from OA tissue. Cells were stimulated with a pro-inflammatory cytokine (interleukin-1b, IL-1b, 5ng/ml) and we used different concentrations (ranging from 50 mM to 1000 mM) of the two H2S donors to investigate their ability to ameliorate the effects of IL-1b on the cells. NO production was quantified through the Griess reaction. Protein levels were visualized through immunocytochemistry and quantified with appropriate software; mRNA expression levels were detected with qRT-PCR. ROS levels were quantified with a fluorescence microscope after DCFH or dihydrorhodamine 1,2,3 treatment. PGE-2 levels were measured with a specific EIA. Results: Treatment with IL-1b caused an increase in NO and PGE-2 production, iNOS protein levels, and SOD2 and MMP3 mRNA and protein levels. GYY4137 and NaHS treatment was effective in reducing NO production down to 25% and 50% of the stimulated values (respectively), although none were able to recover the non stimulated state ( Figure 1A ). Even though H2S might react directly with it, NO reduction was probably the result of a decline in iNOS stimulation, because iNOS protein levels were also reduced by both GYY4137 and NaHS treatment. H2S released by GYY4137 and NaHS probably reacts directly with the ROS present in the OA cells and we saw a reduction in both mRNA and protein levels of SOD2 in the stimulated cells. These effects were also accompanied by a reduction in PGE-2 levels: all GYY4137 concentrations led to about a 60% reduction in PGE-2 in the stimulated cells and low NaHS concentrations (50-200mM) to about a 75% reduction ( Figure 1B) . We also saw reductions in both MMP3 mRNA and protein levels after treatment with the H2S donors. Conclusions: Results obtained so far suggest that there might be a therapeutic window for H2S donors that show anti-inflammatory and antioxidant properties. This might be of interest in the alleviation of OAinduced inflammation processes and it should be further explored. Purpose: Wnt signalling pathway regulates mesenchymal stem cell (MSC) self-renewal and differentiation. In osteoarthritis (OA) the Wnt signalling is altered in MSCs isolated from the bone marrow (BM-MSC) and likely contributing to OA pathogenesis. miRNAs are critical regulators of mesenchymal stem biology and overexpression of specific miRNA (mir335), which in addition is upregulated by the Wnt/b-catenin signalling pathway, has been shown to inhibit osteogenic differentiation. According to these evidences, the aim of this study was to delineate the effect over Wnt genes after mir335 overexpression in BM-MSCs from OA patients. Methods: RNA samples from BM-MSC of three OA patients and three controls were analyzed by quantitative PCR to determine the expression of mir335 and MEST gene (which controls mir335 expression). The effect of mir335 overexpression in Wnt signaling was determined using a GFP gene reporter assay of BM-MSC transduced with a lentiviral vector containing mir335 and GFP in one OA patient. Transducted (GFP+) cells were purified 48h after transduction by fluorescence-activated cell sorting (FACS). Transducted GFP cells as well as non-transducted cells were used as control. Cells were further induced to osteogenic differentiation and studied at 0,10 and 21 days. Simultaneous expression of 84 Wnt signalling pathway related genes were analyzed by a PCR Array profiling. Results: miR335 expression levels was reduced by about 50% in OA patients compared to expression levels found in controls. As expected, MEST gene was also clearly downregulated. A different behaviour was observed during differentiation to osteoblast lineage. At initial stages (0-10 days) BM-MSC transducted with mir335 showed an up-regulation of 16 Wnt signalling pathway related genes. Interestingly, seven out of the 16 were downregulated in the non-transduced cells. These genes includes the PITX2, SFRP1, SFRP4,WIF1,WNT16, WNT2 and WNT6. Purpose: Several studies reported that an increase of subchondral bone area (tAB) is associated with features of radiographic knee osteoarthritis (rOA), such as osteophytes, joint space narrowing or subchondral defects. One cross-sectional study reported that tABs were larger in knees with higher KL grades, based on site readings from the OA initiative (OAI). Here we test the hypotheses that knees with rOA show greater rates of longitudinal tAB change than knees with risk factors but not definite radiographic OA (pre-rOA) or healthy knees without. Methods: Coronal FLASHwe MR images of 899 right knees from OAI participants (539 women, 360 men; age 61.6AE9.5; BMI 28.9AE4.8) were acquired at baseline and 12 month follow-up (public use datasets 0.E.1 and 1.E.1). Based on central radiographic readings (Boston University), 101 knees were classified asymptomatic healthy controls (bilateral KLG 0, no OA risk factors), 254 were pre-rOA (KLG 0&1, with risk factors), and 544 had definite rOA (KLG 2-4). The tAB of the medial and lateral tibia (MT/LT) and weight-bearing (central) femoral condyles (cMF/cLF) were segmented by experienced readers, by matching numbers of slices processed per plate in scan pairs, but with blinding to acquisition order. The size of the tAB was calculated in 3D. Because an increase in tAB was expected, 1-sided non-paired t-tests were used to compare groups, and significance of change was assessed with 1-sided paired t-tests. Results: tAB changes were less than 1% in all strata (Table 1) and were not significantly different from zero in healthy reference knees (SRM range -0.10 to +0.11). Pre-rOA knees had a significant (p<0.05) tAB increase in cMF (SRM +0.10) but not in other plates (SRM 0.05). rOA knees showed significant tAB increases in MT (SRM +0.14), cMF (SRM +0.21) and cLF (SRM +0.15), but not in LT (SRM +0.03). The changes were significantly greater than in rOA than in pre-rOA knees for MT and cLF (p< 0.05), and greater than in healthy controls for MT (p<0.05). In MT, the percent increase in tAB was greater in knees with higher KL grades. Conclusions: Knees with definite rOA show small but significant longitudinal increases in tAB, predominantly in the medial compartment. In the medial tibia, the rate of tAB change was greater in rOA than in pre-rOA or healthy knees. The observed relationship between tAB change and rOAI status in the medial tibia may be due to rOA predominantly affecting the medial compartment (in general and in the OAI) and because femorotibial loading is known to be greater medially than laterally. The current results suggest that longitudinal change in tABs is a feature of structural progression associated with rOA status. Purpose: Subchondral bone changes are an important feature in osteoarthritis (OA). Initial loss of bone volume (BV) followed by sclerosis and thickening of the subchondral bone plate occur during OA development. STR/Ort mice have been suggested to develop OA spontaneously due to reduced endogenous PPARa signalling, possibly by increasing inflammatory processes in the joint and an altering osteoblast phenotype [Watters 2007, Arthritis Rheum] . To confirm the role of PPARa in the development of OA, we have treated STR/Ort mice with fenofibrate, a PPARa agonist, and evaluated inflammation, subchondral changes and OA cartilage damage in this spontaneous OA model. Methods: 8-weeks-old male STR/Ort mice (n¼36) were divided into 3 experimental groups (n¼12 per group). One group received reference diet (Control) whereas the other 2 groups received reference diet mixed with two different dosages of fenofibrate (100 mg/kg bodyweight (BW)/ day or 200 mg/kg BW/day). Mice were euthanized after 16 weeks of treatment at the age of 6 months. mCT was used to quantify subchondral bone volume (Sb.BV) in a pre-defined region of interest and subchondral plate thickness (Sb.Th), in addition to metaphyseal bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp). Level of inflammation was determined by measuring serum amyloid A (SAA). Knee cartilage damage was evaluated by histology using the OARSI scoring method. Results: Mice treated with 200 mg/kg BW/day fenofibrate had a significantly lower amount of subchondral bone, with lower Sb.BV and Sb.Th, as well as a lower amount of metaphyseal bone, with lower BV/TV and Tb.N and elevated Tb.Sp. No significant difference in cartilage damage was found between the groups. Fenofibrate treated mice had significantly lower levels of SAA compared to Control. Although no difference was found in SAA levels between mice with and without cartilage damage, reduced SAA was associated with less Sb.BV, BV/TV and Tb.Th. Conclusions: Systemic inflammation and subchondral bone volume and thickness in the STR/Ort mouse can be reduced by fenofibrate treatment. However, cartilage damage was not influenced. This suggests that PPARa signalling may influence subchondral bone morphology, but is not correlated with cartilage damage in the STR/Ort mouse. Acknowledgment: financial support of Top Institute Pharma (grant T1-213-1), Anna Fonds and Nuts Ohra 
